| scholarly article | Q13442814 |
| P2093 | author name string | E Degryse | |
| Mehtali M | |||
| Dieterle A | |||
| Pavirani A | |||
| Chartier C | |||
| M Mehtali | |||
| C Chartier | |||
| Degryse E | |||
| A Pavirani | |||
| A Dieterle | |||
| M Gantzer | |||
| Gantzer M | |||
| P2860 | cites work | Rapid cloning by homologous recombination in vivo | Q40519954 |
| Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis | Q41226051 | ||
| Viability of λ phages carrying a perfect palindrome in the absence of recombination nucleases | Q41557657 | ||
| Characterisation of two differently processed forms of human recombinant factor IX synthesised in CHO cells transformed with a polycistronic vector | Q44935686 | ||
| The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2 | Q44968237 | ||
| An efficient procedure to select and recover recombinant adenovirus vectors | Q45866724 | ||
| Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter | Q48351986 | ||
| Plasmid-mediated lethality and plasmid multimer formation in an Escherichia coli recBC sbcBC mutant. Involvement of RecF recombination pathway genes. | Q54342674 | ||
| Human adenovirus cloning vectors based on infectious bacterial plasmids. | Q54437284 | ||
| In vivo intermolecular recombination in Escherichia coli: application to plasmid constructions. | Q54590198 | ||
| Evaluation of Escherichia coli recBC sbcBC mutants for cloning by recombination in vivo. | Q54613855 | ||
| A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5 | Q64379529 | ||
| Biochemistry of homologous recombination in Escherichia coli | Q24634614 | ||
| Studies on transformation of Escherichia coli with plasmids | Q27860598 | ||
| A new technique for the assay of infectivity of human adenovirus 5 DNA | Q27860797 | ||
| Selective extraction of polyoma DNA from infected mouse cell cultures | Q29547500 | ||
| Characteristics of a human cell line transformed by DNA from human adenovirus type 5 | Q29547863 | ||
| Upstream and downstream cis-acting elements for cleavage at the L4 polyadenylation site of adenovirus-2. | Q34801348 | ||
| Adenovirus-Based Expression Vectors and Recombinant Vaccines | Q35228887 | ||
| Adenovirus vectors for gene expression | Q35291687 | ||
| Efficient manipulation of the human adenovirus genome as an infectious yeast artificial chromosome clone | Q35559318 | ||
| Generation of adenovirus by transfection of plasmids | Q35686623 | ||
| An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. | Q35748116 | ||
| Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation | Q36230680 | ||
| Plasmid and bacteriophage vectors for excision of intact inserts | Q36298002 | ||
| Rescue of functional replication origins from embedded configurations in a plasmid carrying the adenovirus genome | Q36941297 | ||
| Region E3 of adenovirus: A cassette of genes involved in host immunosurveillance and virus-cell interactions | Q37099438 | ||
| Development of adenovirus vectors for the expression of heterologous genes | Q39585186 | ||
| Alternative cell line for virus isolation | Q40206587 | ||
| In vivo cloning of PCR products in E. coli | Q40412972 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| Adenoviridae | Q193447 | ||
| P304 | page(s) | 4805-4810 | |
| P577 | publication date | 1996-07-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli | |
| P478 | volume | 70 |
| Q40693835 | A 72-bp internal deletion in the left inverted terminal repeat of the bovine adenovirus type 3 genome does not affect virus replication |
| Q35874291 | A Multi Targeting Conditionally Replicating Adenovirus Displays Enhanced Oncolysis while Maintaining Expression of Immunotherapeutic Agents |
| Q42723089 | A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini |
| Q47549547 | A hypoxia- and telomerase-responsive oncolytic adenovirus expressing secretable trimeric TRAIL triggers tumour-specific apoptosis and promotes viral dispersion in TRAIL-resistant glioblastoma |
| Q89899416 | A new gorilla adenoviral vector with natural lung tropism avoids liver toxicity and is amenable for capsid engineering and vector retargeting |
| Q36718570 | A novel adenovirus vector for easy cloning in the E3 region downstream of the CMV promoter |
| Q33251081 | A novel and simple method for construction of recombinant adenoviruses |
| Q35641856 | A novel and simple method for rapid generation of recombinant porcine adenoviral vectors for transgene expression |
| Q28727030 | A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity |
| Q24682328 | A simplified system for generating recombinant adenoviruses |
| Q33520212 | A strategy for adenovirus vector targeting with a secreted single chain antibody |
| Q30928323 | A tail-anchored myotonic dystrophy protein kinase isoform induces perinuclear clustering of mitochondria, autophagy, and apoptosis |
| Q31104314 | AcMNPV core gene ac109 is required for budded virion transport to the nucleus and for occlusion of viral progeny |
| Q40815010 | Activation of adenoviral gene expression by protein IX is not required for efficient virus replication |
| Q40175603 | Ad 2.0: a novel recombineering platform for high-throughput generation of tailored adenoviruses |
| Q33305143 | Adeno-associated viral vectors engineered for macrolide-adjustable transgene expression in mammalian cells and mice |
| Q39596327 | Adeno-associated virus type 2 protein interactions: formation of pre-encapsidation complexes |
| Q40632527 | Adenoviral Transgene Ubiquitination Enhances Mouse Immunization and Class I Presentation by Human Dendritic Cells |
| Q36935134 | Adenoviral vectors for gene therapy |
| Q41866410 | Adenovirus IVa2 protein binds ATP. |
| Q30375982 | Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines. |
| Q24293503 | Adenovirus gene transfer to amelogenesis imperfecta ameloblast-like cells |
| Q39707314 | Adenovirus late-phase infection is controlled by a novel L4 promoter. |
| Q34700810 | Adenovirus particles that display the Plasmodium falciparum circumsporozoite protein NANP repeat induce sporozoite-neutralizing antibodies in mice |
| Q43163170 | Adenovirus serotype 5 L4-22K and L4-33K proteins have distinct functions in regulating late gene expression. |
| Q36323991 | Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake |
| Q27317286 | Adenovirus-Mediated Expression of the p14 Fusion-Associated Small Transmembrane Protein Promotes Cancer Cell Fusion and Apoptosis In Vitro but Does Not Provide Therapeutic Efficacy in a Xenograft Mouse Model of Cancer |
| Q41699782 | Adenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine |
| Q34041940 | Adenoviruses as vectors for delivering vaccines to mucosal surfaces |
| Q64905542 | An Oncolytic Adenovirus Vector Expressing p14 FAST Protein Induces Widespread Syncytium Formation and Reduces Tumor Growth Rate In Vivo. |
| Q34577155 | An adenovirus vector incorporating carbohydrate binding domains utilizes glycans for gene transfer |
| Q33786008 | An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism |
| Q37945220 | An update on canine adenovirus type 2 and its vectors |
| Q39685068 | Antibody-mediated targeted gene transfer to NMDA NR1-containing neurons in rat neocortex by helper virus-free HSV-1 vector particles containing a chimeric HSV-1 glycoprotein C-staphylococcus A protein |
| Q33700607 | Association of Tat with Promoters of PTEN and PP2A Subunits Is Key to Transcriptional Activation of Apoptotic Pathways in HIV-Infected CD4+ T Cells |
| Q21296738 | Bacterial artificial chromosome mutagenesis using recombineering |
| Q38286656 | Bovine adenovirus-3 as a vaccine delivery vehicle. |
| Q36699786 | Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection |
| Q90344595 | Canine Adenovirus 2: A Natural Choice for Brain Circuit Dissection |
| Q34926393 | Canine adenovirus type 2 vector generation via I-Sce1-mediated intracellular genome release |
| Q39588767 | Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer |
| Q39835775 | Cell lines from the Egyptian fruit bat are permissive for modified vaccinia Ankara |
| Q37382109 | Cellular source and amount of vascular endothelial growth factor and platelet-derived growth factor in tumors determine response to angiogenesis inhibitors |
| Q42734186 | Characterization of Empty adenovirus particles assembled in the absence of a functional adenovirus IVa2 protein |
| Q39577664 | Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob |
| Q34322336 | Characterization of human adenovirus 35 and derivation of complex vectors |
| Q34437167 | Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge |
| Q35279932 | Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer |
| Q27472916 | Comparative vaccine studies in HLA-A2.1-transgenic mice reveal a clustered organization of epitopes presented in hepatitis C virus natural infection |
| Q35180550 | Computationally designed adeno-associated virus (AAV) Rep 78 is efficiently maintained within an adenovirus vector. |
| Q39879201 | Conditional repression of the E2 transcription unit in E1-E3-deleted adenovirus vectors is correlated with a strong reduction in viral DNA replication and late gene expression in vitro |
| Q39151214 | Conditionally replicative adenoviral vectors for imaging the effect of chemotherapy on pancreatic cancer cells |
| Q35206396 | Conserved arginines of bovine adenovirus-3 33K protein are important for transportin-3 mediated transport and virus replication |
| Q40794442 | Construction of adenoviral vectors |
| Q39878424 | Construction of adenovirus vectors through Cre-lox recombination |
| Q33851984 | Construction of avian adenovirus CELO recombinants in cosmids |
| Q36890695 | Construction, Rescue, and Characterization of Vectors Derived from Ovine Atadenovirus |
| Q33983262 | Control of gene expression by the retinoic acid-related orphan receptor alpha in HepG2 human hepatoma cells |
| Q35810067 | Cystic fibrosis transmembrane conductance regulator does not affect neutrophil migration across cystic fibrosis airway epithelial monolayers |
| Q40722127 | Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs |
| Q39585255 | Dependence of adenovirus infectivity on length of the fiber shaft domain |
| Q34280138 | Derivation of a myeloid cell-binding adenovirus for gene therapy of inflammation |
| Q40441928 | Development and assessment of human adenovirus type 11 as a gene transfer vector |
| Q39683618 | Development and characterization of bovine x human hybrid cell lines that efficiently support the replication of both wild-type bovine and human adenoviruses and those with E1 deleted |
| Q27676519 | Development of a generic adenovirus delivery system based on structure-guided design of bispecific trimeric DARPin adapters |
| Q34120794 | Development of a targeted gene vector platform based on simian adenovirus serotype 24. |
| Q47558190 | Development of novel vaccine vectors: Chimpanzee adenoviral vectors |
| Q33344440 | Directed evolution generates a novel oncolytic virus for the treatment of colon cancer |
| Q34976257 | Distinct Roles of the Adenovirus E4 ORF3 Protein in Viral DNA Replication and Inhibition of Genome Concatenation |
| Q24293334 | Divergent mitochondrial and endoplasmic reticulum association of DMPK splice isoforms depends on unique sequence arrangements in tail anchors. |
| Q42917817 | Dominant regulation of interendothelial cell gap formation by calcium-inhibited type 6 adenylyl cyclase |
| Q36854089 | E1A and E1B proteins inhibit inflammation induced by adenovirus |
| Q35904034 | E2F/Rb Family Proteins Mediate Interferon Induced Repression of Adenovirus Immediate Early Transcription to Promote Persistent Viral Infection |
| Q64377175 | Effect of Relaxin Expressing Adenovirus on Scar Remodeling: A Preliminary Study |
| Q92748624 | Effect of Relaxin Expression from an Alginate Gel-Encapsulated Adenovirus on Scar Remodeling in a Pig Model |
| Q33770522 | Effective modifications for improved homologous recombination and high-efficiency generation of recombinant adenovirus-based vectors |
| Q24792408 | Efficient adenovirus-mediated gene transfer into primary T cells and thymocytes in a new coxsackie/adenovirus receptor transgenic model |
| Q32082734 | Efficient directional cloning of recombinant adenovirus vectors using DNA-protein complex |
| Q33799667 | Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector |
| Q33252754 | Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli |
| Q36438269 | Efficient generation of recombinant adenoviral vectors by Cre-lox recombination in vitro |
| Q38662649 | Elastic force restricts growth of the murine utricle. |
| Q39580980 | Encapsidation of viral DNA requires the adenovirus L1 52/55-kilodalton protein |
| Q34979041 | Endospanins regulate a postinternalization step of the leptin receptor endocytic pathway |
| Q39597930 | Episomal segregation of the adenovirus enhancer sequence by conditional genome rearrangement abrogates late viral gene expression |
| Q35122385 | Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. |
| Q37369645 | Exploiting features of adenovirus replication to support mammalian kinase production |
| Q28344283 | Expression of 5-lipoxygenase in pulmonary artery endothelial cells |
| Q34445566 | Expression of VP7, a Bluetongue virus group specific antigen by viral vectors: analysis of the induced immune responses and evaluation of protective potential in sheep |
| Q39549150 | Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber. |
| Q33844598 | Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear reorganization |
| Q43157946 | Gene transfer into neural cells in vitro using adenoviral vectors |
| Q31002814 | General strategy for broadening adenovirus tropism. |
| Q36276709 | Generation of an adenovirus-parvovirus chimera with enhanced oncolytic potential. |
| Q33779555 | Generation of cell lines to complement adenovirus vectors using recombination-mediated cassette exchange. |
| Q39606358 | Genetic retargeting of adenovirus: novel strategy employing "deknobbing" of the fiber |
| Q39602429 | Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin |
| Q40012083 | Genetically targeted adenovirus vector directed to CD40-expressing cells |
| Q39960246 | Genome size and structure determine efficiency of postinternalization steps and gene transfer of capsid-modified adenovirus vectors in a cell-type-specific manner |
| Q39437315 | Getting genetic access to natural adenovirus genomes to explore vector diversity |
| Q33678960 | HIV-1 Tat second exon limits the extent of Tat-mediated modulation of interferon-stimulated genes in antigen presenting cells. |
| Q40769181 | Helper virus-free HSV-1 vectors packaged both in the presence of VSV G protein and in the absence of HSV-1 glycoprotein B support gene transfer into neurons in the rat striatum |
| Q40883683 | Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo |
| Q39601760 | Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors |
| Q33740415 | Her2-specific multivalent adapters confer designed tropism to adenovirus for gene targeting |
| Q40632778 | High throughput creation of recombinant adenovirus vectors by direct cloning, green-white selection and I-Sce I-mediated rescue of circular adenovirus plasmids in 293 cells |
| Q30815080 | High-efficiency system for the construction of adenovirus vectors and its application to the generation of representative adenovirus-based cDNA expression libraries |
| Q64374767 | Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Suppresses Human Adenovirus Gene Expression and Replication |
| Q47398490 | Human adenovirus infection causes the cellular MKRN1 E3 ubiquitin ligase degradation involving the viral core protein pVII. |
| Q38682348 | Human adenovirus type 5 vectors deleted of early region 1 (E1) undergo limited expression of early replicative E2 proteins and DNA replication in non-permissive cells. |
| Q35914497 | Human and simian immunodeficiency virus-mediated upregulation of the apoptotic factor TRAIL occurs in antigen-presenting cells from AIDS-susceptible but not from AIDS-resistant species |
| Q33763110 | Human immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: potential role of phosphatidylinositol 3-kinase |
| Q34286779 | Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2 |
| Q24673603 | Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein |
| Q64377365 | Identification of cis-acting sequences required for selective packaging of bovine adenovirus type 3 DNA |
| Q39529490 | Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination |
| Q56989931 | Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates |
| Q39752863 | Improved potency and selectivity of an oncolytic E1ACR2 and E1B19K deleted adenoviral mutant in prostate and pancreatic cancers |
| Q33782356 | In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. |
| Q39946508 | In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46 |
| Q37456186 | In vitro dynamic visualization analysis of fluorescently labeled minor capsid protein IX and core protein V by simultaneous detection |
| Q40336666 | In vitro gene targeting in human hepatoblastoma. |
| Q45869133 | Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer |
| Q34347524 | Intact microtubules support adenovirus and herpes simplex virus infections |
| Q33854633 | Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirus |
| Q24316352 | LEPROT and LEPROTL1 cooperatively decrease hepatic growth hormone action in mice |
| Q33755007 | Linked tumor-selective virus replication and transgene expression from E3-containing oncolytic adenoviruses |
| Q33804926 | Liver-specific alpha 2 interferon gene expression results in protection from induced hepatitis |
| Q42010270 | Localization of the N-terminus of minor coat protein IIIa in the adenovirus capsid. |
| Q64374981 | Long-term correction of hemophilia B using adenoviral delivery of CRISPR/Cas9 |
| Q28609619 | Mammalian sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells |
| Q26750912 | Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens |
| Q33850826 | Microtubule-independent motility and nuclear targeting of adenoviruses with fluorescently labeled genomes |
| Q33697866 | MnSOD upregulation induces autophagic programmed cell death in senescent keratinocytes |
| Q40055106 | Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer |
| Q28365607 | Modifications of eukaryotic initiation factor 4F (eIF4F) in adult cardiocytes by adenoviral gene transfer: differential effects on eIF4F activity and total protein synthesis rates |
| Q64068506 | Modified MHC Class II-Associated Invariant Chain Induces Increased Antibody Responses against Antigens after Adenoviral Vaccination |
| Q34362038 | Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein |
| Q39549432 | Mutational analysis of the avian adenovirus CELO, which provides a basis for gene delivery vectors. |
| Q33855218 | Mutations to bid cleavage sites protect hepatocytes from apoptosis after ischemia/reperfusion injury |
| Q34187531 | Noninvasive monitoring of mRFP1- and mCherry-labeled oncolytic adenoviruses in an orthotopic breast cancer model by spectral imaging |
| Q40408474 | Notch3 is required for arterial identity and maturation of vascular smooth muscle cells |
| Q37145300 | Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors |
| Q51849210 | Oncolytic Adenoviruses in Cancer Treatment. |
| Q39882822 | Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo |
| Q40842998 | Optimization of bovine coronavirus hemagglutinin-estrase glycoprotein expression in E3 deleted bovine adenovirus-3. |
| Q34996749 | Optimization of the helper-dependent adenovirus system for production and potency in vivo |
| Q27304840 | Optogenetics-enabled assessment of viral gene and cell therapy for restoration of cardiac excitability. |
| Q33817933 | Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo |
| Q30476274 | PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a |
| Q42204796 | Pancreatic transduction by helper-dependent adenoviral vectors via intraductal delivery. |
| Q36049440 | Peptide targeting of adenoviral vectors to augment tumor gene transfer |
| Q43632080 | Preparation of two types p53 recombinant adenovirus and quantitative exogenous expression of green fluorescence protein by flow cytometry |
| Q37167960 | Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors |
| Q33640963 | Production and purification of non replicative canine adenovirus type 2 derived vectors |
| Q30226988 | Production of adenovirus vectors and their use as a delivery system for influenza vaccines |
| Q33517124 | Protective role of R-spondin1, an intestinal stem cell growth factor, against radiation-induced gastrointestinal syndrome in mice |
| Q27473469 | Protein-Protein Interactions between Hepatitis C Virus Nonstructural Proteins |
| Q36791710 | RGD peptide-modified adenovirus expressing hepatocyte growth factor and X-linked inhibitor of apoptosis improves islet transplantation. |
| Q35942431 | Rab11A controls the biogenesis of Birbeck granules by regulating Langerin recycling and stability |
| Q39683249 | Rapid construction of adenoviral vectors by lambda phage genetics |
| Q45874251 | Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent. |
| Q36949857 | Recombinant adenovirus as a methodology for exploration of physiologic functions of growth factor pathways |
| Q38961427 | Recombinant bovine adenovirus-3 co-expressing bovine respiratory syncytial virus glycoprotein G and truncated glycoprotein gD of bovine herpesvirus-1 induce immune responses in cotton rats |
| Q30957737 | Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium |
| Q33819873 | Regulation of adenovirus-mediated transgene expression by the viral E4 gene products: requirement for E4 ORF3. |
| Q24304483 | Regulation of endothelial cell cytoskeletal reorganization by a secreted frizzled-related protein-1 and frizzled 4- and frizzled 7-dependent pathway: role in neovessel formation |
| Q40390936 | Regulation of neurite outgrowth in N1E-115 cells through PDZ-mediated recruitment of diacylglycerol kinase zeta |
| Q33822773 | Replication-defective bovine adenovirus type 3 as an expression vector |
| Q39732556 | Requirement of the adenovirus IVa2 protein for virus assembly |
| Q34699410 | Retargeting adenoviral vectors to improve gene transfer into tumors |
| Q34120709 | Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX. |
| Q41864063 | Role for the L1-52/55K protein in the serotype specificity of adenovirus DNA packaging |
| Q39604759 | Role for the adenovirus IVa2 protein in packaging of viral DNA |
| Q64374656 | Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine |
| Q55513326 | Seamless assembly of recombinant adenoviral genomes from high-copy plasmids. |
| Q35170422 | Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. |
| Q36775480 | Soluble receptor-mediated selective inhibition of VEGFR and PDGFRbeta signaling during physiologic and tumor angiogenesis |
| Q58866812 | Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity |
| Q35695799 | Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation |
| Q39601191 | Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors |
| Q35153978 | Syndecan 4 is involved in mediating HCV entry through interaction with lipoviral particle-associated apolipoprotein E |
| Q37693810 | T cells induced by recombinant chimpanzee adenovirus alone and in prime-boost regimens decrease chimeric EcoHIV/NDK challenge virus load |
| Q41646089 | TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice |
| Q40402866 | Targeted gene transfer to nigrostriatal neurons in the rat brain by helper virus-free HSV-1 vector particles that contain either a chimeric HSV-1 glycoprotein C-GDNF or a gC-BDNF protein |
| Q52431082 | Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas9. |
| Q37227135 | Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody |
| Q34226547 | Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge |
| Q36850837 | Tat engagement of p38 MAP kinase and IRF7 pathways leads to activation of interferon-stimulated genes in antigen-presenting cells. |
| Q37150920 | Tat-induced FOXO3a is a key mediator of apoptosis in HIV-1-infected human CD4+ T lymphocytes |
| Q42577485 | The C-terminal domains of adenovirus serotype 5 protein IX assemble into an antiparallel structure on the facets of the capsid. |
| Q38880684 | The Human Adenovirus Type 5 L4 Promoter Is Negatively Regulated by TFII-I and L4-33K. |
| Q47269122 | The Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING. |
| Q34717916 | The L4 22-kilodalton protein plays a role in packaging of the adenovirus genome |
| Q28574430 | The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes |
| Q30415541 | The adenovirus L4-22K protein has distinct functions in the posttranscriptional regulation of gene expression and encapsidation of the viral genome |
| Q30421658 | The adenovirus L4-22K protein is multifunctional and is an integral component of crucial aspects of infection |
| Q30416104 | The adenovirus L4-33K protein regulates both late gene expression patterns and viral DNA packaging |
| Q33853916 | The adenovirus major core protein VII is dispensable for virion assembly but is essential for lytic infection |
| Q39106880 | The human adenovirus 5 L4 promoter is activated by cellular stress response protein p53. |
| Q33201422 | The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3 |
| Q27486151 | The major form of hepatitis C virus alternate reading frame protein is suppressed by core protein expression |
| Q41895997 | The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic. |
| Q40372177 | The nucleotide sequence and a first generation gene transfer vector of species B human adenovirus serotype 3. |
| Q24290927 | The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response |
| Q33730717 | Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL. |
| Q36640360 | Therapeutic efficacy of Tyro3, Axl, and Mer tyrosine kinase agonists in collagen-induced arthritis |
| Q37127836 | Therapeutic efficacy of an oncolytic adenovirus containing RGD ligand in minor capsid protein IX and Fiber, Δ24DoubleRGD, in an ovarian cancer model |
| Q37270929 | Therapeutic vaccines for non-Hodgkin B-cell lymphoma. |
| Q36387903 | Thermostability/infectivity defect caused by deletion of the core protein V gene in human adenovirus type 5 is rescued by thermo-selectable mutations in the core protein X precursor |
| Q33859402 | Transduction and oncolytic profile of a potent replication-competent adenovirus 11p vector (RCAd11pGFP) in colon carcinoma cells |
| Q41900379 | Transposon-assisted cloning and traceless mutagenesis of adenoviruses: Development of a novel vector based on species D. |
| Q39505379 | Treatment of pancreatic cancer with an oncolytic adenovirus expressing interleukin-12 in Syrian hamsters. |
| Q39561803 | Truncating the i-leader open reading frame enhances release of human adenovirus type 5 in glioma cells |
| Q35162649 | VEGF is essential for the growth and migration of human hepatocellular carcinoma cells |
| Q36387929 | Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses for pan-carcinoma application |
| Q33581711 | Viral DNA synthesis-dependent titration of a cellular repressor activates transcription of the human adenovirus type 2 IVa2 gene |
Search more.